These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 22273313)
21. How to optimise clopidogrel therapy? Reducing the low-response incidence by aggregometry-guided therapy modification. Neubauer H; Lask S; Engelhardt A; Mügge A Thromb Haemost; 2008 Feb; 99(2):357-62. PubMed ID: 18278186 [TBL] [Abstract][Full Text] [Related]
22. Functional effects of high clopidogrel maintenance dosing in patients with inadequate platelet inhibition on standard dose treatment. Angiolillo DJ; Costa MA; Shoemaker SB; Desai B; Bernardo E; Suzuki Y; Charlton RK; Zenni MM; Guzman LA; Bass TA Am J Cardiol; 2008 Feb; 101(4):440-5. PubMed ID: 18312754 [TBL] [Abstract][Full Text] [Related]
23. Measurement of antiplatelet inhibition during neurointerventional procedures: the effect of antithrombotic duration and loading dose. Pandya DJ; Fitzsimmons BF; Wolfe TJ; Hussain SI; Lynch JR; Ortega-Gutierrez S; Zaidat OO J Neuroimaging; 2010 Jan; 20(1):64-9. PubMed ID: 19018951 [TBL] [Abstract][Full Text] [Related]
24. A double-blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 days. von Beckerath N; Kastrati A; Wieczorek A; Pogatsa-Murray G; Sibbing D; Graf I; Schömig A Eur Heart J; 2007 Aug; 28(15):1814-9. PubMed ID: 17272357 [TBL] [Abstract][Full Text] [Related]
25. Common sequence variations in the P2Y12 and CYP3A5 genes do not explain the variability in the inhibitory effects of clopidogrel therapy. Smith SM; Judge HM; Peters G; Armstrong M; Fontana P; Gaussem P; Daly ME; Storey RF Platelets; 2006 Jun; 17(4):250-8. PubMed ID: 16769602 [TBL] [Abstract][Full Text] [Related]
26. Comparison of conventional aggregometry with VASP for monitoring P2Y12-specific platelet inhibition. Aradi D; Magyarlaki T; Tokés-Füzesi M; Rideg O; Vorobcsuk A; Komócsi A Platelets; 2010; 21(7):563-70. PubMed ID: 20642320 [TBL] [Abstract][Full Text] [Related]
27. Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study. Patti G; Nusca A; Mangiacapra F; Gatto L; D'Ambrosio A; Di Sciascio G J Am Coll Cardiol; 2008 Sep; 52(14):1128-33. PubMed ID: 18804738 [TBL] [Abstract][Full Text] [Related]
28. Functional variability of platelet response to clopidogrel correlates with P2Y(12) receptor occupancy. Bal Dit Sollier C; Berge N; Boval B; Hovsepian L; Drouet L Thromb Haemost; 2009 Jan; 101(1):116-22. PubMed ID: 19132197 [TBL] [Abstract][Full Text] [Related]
29. Response to aspirin and clopidogrel monitored with different platelet function methods. Mani H; Linnemann B; Luxembourg B; Kirchmayr K; Lindhoff-Last E Platelets; 2006 Aug; 17(5):303-10. PubMed ID: 16928602 [TBL] [Abstract][Full Text] [Related]
31. Functional impact of high clopidogrel maintenance dosing in patients undergoing elective percutaneous coronary interventions. Results of a randomized study. Angiolillo DJ; Bernardo E; Palazuelos J; Desai B; Weisberg I; Alfonso F; Guzman LA; Hernández-Antolin R; Zenni MZ; Macaya C; Fernandez-Ortiz A; Bass TA Thromb Haemost; 2008 Jan; 99(1):161-8. PubMed ID: 18217149 [TBL] [Abstract][Full Text] [Related]
32. A head-to-head comparison between the VerifyNow P2Y12 assay and light transmittance aggregometry for monitoring the individual platelet response to clopidogrel in patients undergoing elective percutaneous coronary intervention. van Werkum JW; van der Stelt CA; Seesing TH; Hackeng CM; ten Berg JM J Thromb Haemost; 2006 Nov; 4(11):2516-8. PubMed ID: 16938130 [No Abstract] [Full Text] [Related]
33. Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis. Buonamici P; Marcucci R; Migliorini A; Gensini GF; Santini A; Paniccia R; Moschi G; Gori AM; Abbate R; Antoniucci D J Am Coll Cardiol; 2007 Jun; 49(24):2312-7. PubMed ID: 17572245 [TBL] [Abstract][Full Text] [Related]
35. Clinical outcomes of high on-treatment platelet reactivity in Koreans receiving elective percutaneous coronary intervention (from results of the CROSS VERIFY study). Park KW; Jeon KH; Kang SH; Oh IY; Cho HJ; Lee HY; Kang HJ; Park SK; Koo BK; Oh BH; Park YB; Kim HS Am J Cardiol; 2011 Dec; 108(11):1556-63. PubMed ID: 21880289 [TBL] [Abstract][Full Text] [Related]